Robert J. Bitterman, Interim Executive Chairman at Phio Pharmaceuticals Corp. (PHIO), bought 2,715 shares at $0.40 ($1K) on 2022-11-29, disclosed to the SEC on 2022-11-29.
Open-market purchase of $1k PHIO by Interim Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.42 | 2,500 | $1K | 92.4% |
| 2 | $0.40 | 215 | $86 | 7.6% |
| Total | $0.42 avg | 2,715 | $1K | 100% |
| Filing → |
| PHIO | BUY | 2026-01-02 | $5K | — | Filing → |
| PHIO | BUY | 2025-12-29 | $5K | — | Filing → |
| PHIO | BUY | 2025-11-24 | $6K | — | Filing → |